Structure-activity relationship studies on cholecystokinin: analogues with partial agonist activity.
In the present study, hepta- and octapeptide analogues of the C-terminal part of cholecystokinin, modified on the C-terminal phenylalanine residue, were synthesized. CCK analogues were prepared in which the peptide bond between aspartic acid and phenylalanine had or had not been modified and were lacking the C-terminal primary amide function. These CCK derivatives were able to cause full stimulation of amylase release from rat pancreatic acini but without a decrease in amylase release at supramaximal concentrations. There was a close relationship between the abilities of these derivatives to stimulate amylase release and their abilities to inhibit binding of 125I-BH-CCK-9 to CCK receptors on rat and guinea pig pancreatic acini. These CCK analogues were also able to recognize the guinea pig brain CCK receptors, some of them being particularly potent. The findings indicate that the aromatic ring of phenylalanine is important for the binding to brain and pancreatic CCK receptors, whereas the C-terminal primary amide function is not essential for the binding to pancreatic CCK receptors but is crucial for biological activity of rat pancreatic acini.
D000681:Amylases / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism; D002766:Cholecystokinin / Q000031:analogs & derivatives / Q000502:physiology; D006168:Guinea Pigs; D008297:Male; D010179:Pancreas / Q000201:enzymology; D051381:Rats; D011949:Receptors, Cholecystokinin / Q000378:metabolism; D012844:Sincalide / Q000031:analogs & derivatives / Q000378:metabolism; D013329:Structure-Activity Relationship; D013388:Succinimides / Q000378:metabolism
D011949:Receptors, Cholecystokinin; D013388:Succinimides; C055121:Bolton Hunter-cholecystokinin nonapeptide; D002766:Cholecystokinin; D000681:Amylases; D012844:Sincalide